Welcome to the Empowered Patient Podcast with Karen Jagoda. This show is a window into the latest innovations in applying generative AI, novel therapeutics and vaccines, and the changing dynamics in the medical and healthcare environment. One focus is on how providers, pharmaceutical companies, and payers are empowering patients. In addition, conversations are often about how providers, care facilities, pharmaceutical companies, and payers are being empowered by technology to improve patient outcomes and reduce friction across the healthcare landscape.
Popular Topics
- Virtual and digital health
- Use of AI, ML, and LLM in healthcare and drug discovery, development, trials
- Value-based healthcare
- Precision and stratified medicine
- Integration of digital technology into existing workflow and procedures
- Next-generation immuno, cell, and gene therapies
- Vaccines
- Biomarkers, sequencing, and imaging
- Rare diseases
- MedTech and medical devices
- Clinical trials
- Addressing Social Determinants of Health
- Treating chronic conditions like obesity and pain
- Clinician and staff burnout
The audience includes life science leaders, researchers, medical professionals, patient advocates, digital health entrepreneurs, patients, caregivers, healthcare solution providers, students, journalists, and investors.
Check out our new EmpoweredPatient.Solutions site where you can quickly search all of the Empowered Patient Podcast interviews by any word or phrase to identify useful resources, potential partners, and insights about the life sciences landscape.
Identifying and Managing Allergies with Personalized Nasal Solutions with Dr. Shuba Iyengar Allermi TRANSCRIPT
Download PDFFeb 19, 2024
Dr. Shuba Iyengar, Co-Founder and Chief Medical Officer of Allermi, is focused on providing better care and access to allergy treatments. Allermi has developed a personalized approach to diagnosing allergies and personalizing nasal spray formulations to provide a more precise solution to those suffering from...
Feb 19, 2024
Dr. Shuba Iyengar, Co-Founder and Chief Medical Officer of Allermi, is focused on providing better care and access to allergy treatments. Allermi has developed a personalized approach to diagnosing allergies and personalizing nasal spray formulations to provide a more precise solution to those suffering from...
Using Antibody Therapeutics to Block Allergic Reactions with Dr. Jessica Grossman IgGenix TRANSCRIPT
Download PDFAug 22, 2022
Dr. Jessica Grossman is the CEO of an early stage biotech, IgGenix, the world leader in discovering and characterizing IgE antibodies which have been identified as the cause of allergies. With an initial focus on peanut allergy, IgGenix is developing a plan to use a subcutaneous injection to block specific allergic...
Aug 22, 2022
Dr. Jessica Grossman is the CEO of an early stage biotech, IgGenix, the world leader in discovering and characterizing IgE antibodies which have been identified as the cause of allergies. With an initial focus on peanut allergy, IgGenix is developing a plan to use a subcutaneous injection to block specific allergic...
Oct 28, 2021
Dr. Nicole Wulf is a clinical pharmacist at FDB and has recently published a study of the current evidence regarding iodine containing compounds and iodine allergy cross-reactivity. Overall they found that there was a lack of evidence that iodine is an allergen and can cause hypersensitivity reactions particularly from...